By Pooja Toshniwal Paharia Reviewed by Susha Cheriyedath, M.Sc. Apr 27 2026 As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access. GLP-1 receptor agonists: The good, the bad, and the ugly - A comprehensive guide for NPs . Image Credit: zimmytws / Shutterstock A recent review published in  The Nurse Practitioner highlights the expanding clinical role of